Welcome to our dedicated page for Q32 Bio SEC filings (Ticker: FIXX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Q32 Bio's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Q32 Bio's regulatory disclosures and financial reporting.
Q32 Bio Inc. (FIXX) director and CEO Jodie Pope Morrison reported a sale of 9,845 shares of common stock on August 25, 2026, at $16.56 per share. According to the disclosure, the shares were sold automatically to cover tax withholding obligations arising from vesting restricted stock units, not at the reporting person’s discretion. Following this transaction, Morrison directly holds 343,259 shares of Q32 Bio common stock.
Q32 Bio Inc. (FIXX) reported that officer Lee Kalowski, CFO and President, had 3,972 shares of common stock sold on 2026-08-25 at $16.56 per share. A footnote states these shares were sold automatically to cover tax withholding obligations on vesting RSUs, not at the officer’s discretion. Following this transaction, Kalowski directly holds 138,471 shares of Q32 Bio common stock.
Q32 Bio Inc. (FIXX) reported that Chief Scientific Officer Shelia M. Violette had an automatic sale of 2,798 shares of common stock on 2026-08-25 at $16.56 per share. The shares were sold to cover tax withholding obligations arising from the vesting of restricted stock units and were not sold at her discretion. Following this transaction, she holds 127,771 shares directly and has 36,277 shares reported as indirectly held through Violette Holdings LLC, for which she disclaims beneficial ownership except to the extent of any pecuniary interest.